Lincoln Pharmaceuticals Ltd. (LINCOLN)
Market Open
7 Aug, 10:00
XNSE ₹
600. 15
-6.05
-0.998%
₹
- Market Cap
- P/E Ratio
6% Div Yield
22,325 Volume
- Eps
₹ 606.2
Previous Close Want to track LINCOLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lincoln Pharmaceuticals Ltd. (LINCOLN) Statistics
Valuation metrics
Market Cap -
Enterprise value 11.74B
Trailing P/E (ttm) 13.67
Forward P/E -
PEG ratio 2.03
Price/Sales (ttm) 1.79
Price/Book (mrq) 1.59
Enterprise Value/Revenue 1.75
Enterprise Value/EBITDA 10.12
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 26.64K
Average volume (90 days) 72.3K
Price summary
52-Week low 440
52-Week high 770
Beta -
50-Day moving average 602.6
200-Day moving average 602.22
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.8
Trailing annual dividend yield 0.003%
5-Year annual dividend yield -
Payout ratio 0
Dividend Date 30 Oct 2025
Ex-Dividend Date 12 Sep 2025
Last split factor 2:10
Last split Date 19 Mar 2009
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.13%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 335.1
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 43.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 120.45
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 5.25%
Book value per share (mrq) 378.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
